Search

Your search keyword '"Vita, E"' showing total 2,722 results

Search Constraints

Start Over You searched for: Author "Vita, E" Remove constraint Author: "Vita, E"
2,722 results on '"Vita, E"'

Search Results

1. AI-Assisted Hate Speech Moderation—How Information on AI-Based Classification Affects the Human Brain-In-The-Loop

3. Silicone Embedded FBGs for Force Sensing

4. DianaWeb: Before and After Study Online Based Participatory Research on Breast Cancer Women (DianaWeb)

7. Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed

11. 145P Identification of next generation sequencing (NGS)-based genomic signature predicting resistance to immunotherapy (IO) in patients (pts) with metastatic non-small cell lung cancer (mNSCLC): A single-center cohort study

12. Alcune riflessioni sui rapporti tra la memoria dei campi di concentramento fascisti e le nuove forme digitali di divulgazione storica

13. Pluriclassi, scuole rurali, scuole a ciclo unico dall’Unità d’Italia al 1948

15. Transformation zur Nachhaltigkeit: warum wir eine Literacy für nachhaltigen Konsum brauchen

16. Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study

17. Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study

18. Salvage Surgery After First-Line Alectinib for Locally-Advanced/Metastatic ALK-Rearranged NSCLC: Pathological Response and Perioperative Results

23. 1538P Prognostic impact of leptin (LEP)-mediated meta-inflammation (MI) in patients (pts) receiving maintenance immunotherapy (IT) for extensive-stage small cell lung cancer (ES-SCLC)

24. 1618P Impact of body composition phenotypes on outcome of non-small cell lung cancer patients treated with immunotherapy

25. EP05.03-008 Surgery after First-Line Alectinib for (Locally) Advanced ALK-rearranged NSCLC: Pathological Response and Peri-Operative Results

26. EP10.01-011 Prognostic Impact of Body Composition Phenotypes in Non-small Cell Lung Cancer Patients Receiving First-Line Pembrolizumab

27. Verbraucherschutz und Digitalisierung: Ausgewählte Problemfelder und aktuelle Themen in der digitalen Welt

28. Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study

33. Massimo PISTACCHI (a cura di), Vive Voci. L’intervista come fonte di documentazione, Roma, Donzelli, 2011, 207 pp.

34. PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: A systematic review and meta-analysis

36. 1675P Potential effect of adipose tissue distribution on clinical outcomes in advanced non-small cell lung cancer (NSCLC) patients (pts) receiving first-line pembrolizumab (PEMBRO)

37. Transformation zur Nachhaltigkeit: Warum wir eine Literacy für nachhaltigen Konsum brauchen

38. A visual quality control scale for clinical arterial spin labeling images

39. PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors

42. Dal bambino maltrattato all’adolescente a rischio: il ruolo dei fattori di sviluppo nel rischio di recidiva per minori autori di reato

43. 104P Fast progression in high PD-L1 NSCLC treated with pembrolizumab in first-line: A prognostic scoring system based on clinical features

45. P35.14 NGS-Based Molecular Profiling of ‘Quadruple-Negative’ (EGFR/KRAS/ALK/ROS1) Advanced Non-Small-Cell Lung Cancer (aNSCLC).

46. Impact of the environment on the health: From theory to practice

47. Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 11 Medical and Health Sciences 1103 Clinical Sciences

49. ExploreASL: an image processing pipeline for multi-center ASL perfusion MRI studies

50. First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status

Catalog

Books, media, physical & digital resources